LC PRS: Factors Affecting Participation in Lung Cancer Genomic Testing (H-50553)

Introduction: Lung cancer is a leading cause of cancer-related deaths in the United States, with high incidence and death rates among Non-Hispanic blacks and Non-Hispanic whites. Blood tests have recently been developed to identify individuals who may be at increased risk for developing lung cancer and to detect the presence of lung cancer at a very early stage (biomarker testing) based on genetic markers. This study seeks to develop a clearer understanding of factors that may influence the clinical uptake of such tests should they become commercially available. 

Purpose: This study seeks to identify individual and system factors that could affect clinical uptake of polygenic risk and biomarker testing for lung cancer.

Design: This study comprises two parts.

• Part 1 involves a brief survey and qualitative interview of African-American and Non-Hispanic White patients
• Part 2 involves a one-time survey and qualitative interview with healthcare providers

Eligibility

Adults over the age of 18  who are fluent in English are eligible to participate. For their time and effort, participants will receive a $20 gift card upon completion of the survey and a $30 gift card upon completion of the interview. 

Funding

Grant funding from National Cancer Institute.

#U19 CA203654-S